Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - Zoetis Inc. | d381653ds1a.htm |
| EX-15.1 - LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION - Zoetis Inc. | d381653dex151.htm |
| EX-10.14 - MASTER MANUFACTURING AND SUPPLY AGREEMENT (PFIZER AS MANUFACTURER) - Zoetis Inc. | d381653dex1014.htm |
| EX-3.2 - FORM OF AMENDED AND RESTATED BY-LAWS OF THE REGISTRANT - Zoetis Inc. | d381653dex32.htm |
| EX-3.1 - FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT - Zoetis Inc. | d381653dex31.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Pfizer Inc.:
We consent to the use of our audit report dated August 10, 2012 on the combined financial statements of Zoetis Inc., (the animal health business unit of Pfizer Inc.) as of December 31, 2011 and 2010 and for each of the years in the three-year period ended December 31, 2011 included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
New York, New York
October 10, 2012